Abstract
Background
Despite progress in shunt valve technology, CSF overdrainage is still one of the most frequent complications in shunt-treated hydrocephalus. Particularly with regard to young and adolescent patients, treatment of manifest overdrainage is complicated by several hardly influenceable factors such as increasing height and mobility. Therefore, the aim of this study was to evaluate the therapeutic efficiency of the new adjustable gravitational valve, proSA.
Methods
Sixty-four shunt-treated young hydrocephalus patients aged 1.8–41.4 years (15.5 ± 10.5 years) suffering from clinical and/or radiological overdrainage underwent shunt revision surgery with the implantation of the new proSA valve. Clinical outcome after a 1-year follow-up period, pumping function of the valve chambers as well as the number of necessary postoperative valve adjustments were examined.
Results
Fifty-five patients completed the study as planned. All reported a significant improvement of their clinical condition; 91 % described a complete resolution in symptoms related to overdrainage. Preoperatively, more than 85 % of the valve chambers showed no or very slow refilling with CSF. After a year of proSA treatment, more than 90 % exhibited a normal valve chamber function. During the follow-up period, a total of 136 valve adjustments were necessary. None of the proSA valves had to be surgically revised.
Conclusions
The postoperative adjustability of the opening pressure level is the advantage of the new gravitational valve. The good clinical outcome is attributed to the new valve technology. The proSA appears to be a promising shunt valve to overcome overdrainage in adolescent and adult hydrocephalus patients.
Similar content being viewed by others
References
Antes S, Eymann R, Schmitt M, Kiefer M (2012) Pathophysiology of brainstem lesions due to overdrainage. Acta Neurochir Suppl 113:177–180
Arnell K, Eriksson E, Olsen L (2006) The programmable adult Codman Hakim valve is useful even in very small children with hydrocephalus. A 7-year retrospective study with special focus on cost/benefit analysis. Eur J Pediatr Surg 16(1):1–7
Aschoff A, Kremer P, Benesch C, Fruh K, Klank A, Kunze S (1995) Overdrainage and shunt technology. A critical comparison of programmable, hydrostatic and variable-resistance valves and flow-reducing devices. Childs Nerv Syst 11(4):193–202
Baskin JJ, Manwaring KH, Rekate HL (1998) Ventricular shunt removal: the ultimate treatment of the slit ventricle syndrome. J Neurosurg 88(3):478–484
Boon AJ, Tans JT, Delwel EJ, Egeler-Peerdeman SM, Hanlo PW, Wurzer HA, Avezaat CJ, de Jong DA, Gooskens RH, Hermans J (1998) Dutch Normal-Pressure-Hydrocephalus Study. Randomized comparison of low- and medium-pressure shunts. J Neurosurg 88(3):490–495
Carmel PW, Albright AL, Adelson PD, Canady A, Black P, Boydston W, Kneirim D, Kaufman B, Walker M, Luciano M, Pollack IF, Manwaring K, Heilbrun MP, Abbott IR, Rekate H (1999) Incidence and management of subdural hematoma/hygroma with variable- and fixed-pressure differential valves: a randomized, controlled study of programmable compared with conventional valves. Neurosurg Focus 7(4):e7
Cedzich C, Wiessner A (2003) The treatment of hydrocephalus in infants and children using hydrostatic valves. Zentralbl Neurochir 64(2):51–57
Chapman PH, Cosman ER, Arnold MA (1990) The relationship between ventricular fluid pressure and body position in normal subjects and subjects with shunts: a telemetric study. Neurosurgery 26(2):181–189
Dauch WA, Zimmermann R (1990) Normal pressure hydrocephalus. An evaluation 25 years following the initial description. Fortschr Neurol Psychiatr 58(5):178–190
Decq P, Barat JL, Duplessis E, Leguerinel C, Gendrault P, Keravel Y (1995) Shunt failure in adult hydrocephalus: flow-controlled shunt versus differential pressure shunts—a cooperative study in 289 patients. Surg Neurol 43(4):333–339
Di Rocco C, Marchese E, Velardi F (1994) A survey of the first complication of newly implanted CSF shunt devices for the treatment of nontumoral hydrocephalus. Cooperative survey of the 1991–1992 Education Committee of the ISPN. Childs Nerv Syst 10(5):321–327
Drake JM, Kestle JR, Milner R, Cinalli G, Boop F, Piatt J Jr, Haines S, Schiff SJ, Cochrane DD, Steinbok P, MacNeil N (1998) Randomized trial of cerebrospinal fluid shunt valve design in pediatric hydrocephalus. Neurosurgery 43(2):294–303
Eymann R, Steudel WI, Kiefer M (2007) Pediatric gravitational shunts: initial results from a prospective study. J Neurosurg 106(3 Suppl):179–184
Faulhauer K, Schmitz P (1978) Overdrainage phenomena in shunt treated hydrocephalus. Acta Neurochir (Wien) 45(1–2):89–101
Freimann FB, Sprung C (2012) Shunting with gravitational valves—can adjustments end the era of revisions for overdrainage-related events? J Neurosurg 117(6):1197–1204
Gruber RW, Roehrig B (2010) Prevention of ventricular catheter obstruction and slit ventricle syndrome by the prophylactic use of the Integra antisiphon device in shunt therapy for pediatric hypertensive hydrocephalus: a 25-year follow-up study. J Neurosurg Pediatr 5(1):4–16
Haberl EJ, Messing-Juenger M, Schuhmann M, Eymann R, Cedzich C, Fritsch MJ, Kiefer M, Van Lindert EJ, Geyer C, Lehner M, Rohde V, Stroux A, von Berenberg P (2009) Experiences with a gravity-assisted valve in hydrocephalic children. Clinical article. J Neurosurg Pediatr 4(3):289–294
Hanlo PW, Cinalli G, Vandertop WP, Faber JA, Børgesen SE, Boschert J, Chumas P, Eder H, Pople IK, Serlo W, Vizthum E (2003) Treatment of hydrocephalus determined by the European Orbis Sigma Valve II survey: a multicenter prospective 5-year shunt survival study in children and adults in whom a flow-regulating shunt was used. J Neurosurg 99(1):52–57
Kay AD, Fisher AJ, O’Kane C, Richards HK, Pickard JD (2000) A clinical audit of the Hakim programmable valve in patients with complex hydrocephalus. Br J Neurosurg 14(6):535–543
Kestle J, Drake J, Milner R, Sainte-Rose C, Cinalli G, Boop F, Piatt J, Haines S, Schiff S, Cochrane D, Steinbok P, MacNeil N (2000) Long-term follow-up data from the Shunt Design Trial. Pediatr Neurosurg 33(5):230–236
Kiefer M (2012) Treatment of hydrocephalus. Radiologe 52(9):833–839
Kiefer M, Eymann R (2010) Gravitational shunt complications after a five-year follow-up. Acta Neurochir Suppl 106:107–112
Kiefer M, Eymann R, Meier U (2002) Five years experience with gravitational shunts in chronic hydrocephalus of adults. Acta Neurochir (Wien) 144(8):755–767
Kremer P, Aschoff A, Kunze S (1994) Risks of using siphon-reducing devices. Childs Nerv Syst 10(4):231–235
Lemcke J, Meier U (2010) Improved outcome in shunted iNPH with a combination of a Codman Hakim programmable valve and an Aesculap-Miethke ShuntAssistant. Cent Eur Neurosurg 71(3):113–116
Maroulis H, Halmagyi GM, Heard R, Cook RJ (2008) Sylvian aqueduct syndrome with slit ventricles in shunted hydrocephalus due to adult aqueduct stenosis. J Neurosurg 109(5):939–943
Piatt JH Jr (1996) Pumping the shunt revisited. A longitudinal study. Pediatr Neurosurg 25(2):73–76
Pollack IF, Albright AL, Adelson PD (1999) A randomized, controlled study of a programmable shunt valve versus a conventional valve for patients with hydrocephalus. Neurosurgery 45(6):1399–1411
Portnoy HD, Schulte RR, Fox JL, Croissant PD, Tripp L (1973) Anti-siphon and reversible occlusion valves for shunting in hydrocephalus and preventing post-shunt subdural hematomas. J Neurosurg 38(6):729–738
Pudenz RH, Foltz EL (1991) Hydrocephalus: overdrainage by ventricular shunts. A review and recommendations. Surg Neurol 35(3):200–212
Rekate HL (1993) Classification of slit-ventricle syndromes using intracranial pressure monitoring. Pediatr Neurosurg 19(1):15–20
Rekate HL (2004) The slit ventricle syndrome: advances based on technology and understanding. Pediatr Neurosurg 40(6):259–263
Rekate HL (2010) Antisiphon device. J Neurosurg Pediatr 5(1):1–2
Rohde V, Haberl EJ, Ludwig H, Thomale UW (2009) First experiences with an adjustable gravitational valve in childhood hydrocephalus. J Neurosurg Pediatr 3(2):90–93
Sainte-Rose C (1993) Shunt obstruction: a preventable complication? Pediatr Neurosurg 19(3):156–164
Sainte-Rose C, Piatt JH, Renier D, Pierre-Kahn A, Hirsch JF, Hoffman HJ, Humphreys RP, Hendrick EB (1991–1992) Mechanical complications in shunts. Pediatr Neurosurg 17(1):2–9
Sprung C, Schlosser HG, Lemcke J, Meier U, Messing-Jünger M, Trost HA, Weber F, Schul C, Rohde V, Ludwig HC, Höpfner J, Sepehrnia A, Mirzayan MJ, Krauss JK (2010) The adjustable proGAV shunt: a prospective safety and reliability multicenter study. Neurosurgery 66(3):465–474
Toma AK, Tarnaris A, Kitchen ND, Watkins LD (2011) Use of the proGAV shunt valve in normal-pressure hydrocephalus. Neurosurgery 68(2 Suppl Operative):245–249
Vanneste J, Augustijn P, Dirven C, Tan WF, Goedhart ZD (1992) Shunting normal-pressure hydrocephalus: do the benefits outweigh the risks? A multicenter study and literature review. Neurology 42(1):54–59
Weinzierl MR, Hans FJ, Stoffel M, Oertel MF, Korinth MC (2012) Experience with a gravitational valve in the management of symptomatic overdrainage in children with shunts. J Neurosurg Pediatr 9(5):468–472
Weinzierl MR, Rohde V, Gilsbach JM, Korinth M (2008) Management of hydrocephalus in infants by using shunts with adjustable valves. J Neurosurg Pediatr 2(1):14–18
Yamashita N, Kamiya K, Yamada K (1999) Experience with a programmable valve shunt system. J Neurosurg 91(1):26–31
Zemack G, Romner B (2002) Adjustable valves in normal-pressure hydrocephalus: a retrospective study of 218 patients. Neurosurgery 51(6):1392–1400
Acknowledgments
We thank Dr. Samuel Orie (Department of Neurosurgery, Saarland University Medical Center and Saarland University Faculty of Medicine, Homburg/Saar, Germany) for revising the manuscript with respect to English grammar and language.
Conflicts of interest
Christoph A. Tschan, Sebastian Antes and Alexandra Huthmann received some financial compensation from Aesculap Miethke AG (Tuttlingen, Germany) for attending medical conferences. The authors declare that there have been no financial donations associated with this study. There is also no financial interest in the presented technique.
Author information
Authors and Affiliations
Corresponding author
Additional information
Comment
The authors analyzed the functions and complications of an adjustable gravitational valve retrospectively. The short-term follow-up of 1 year was completed in 55 of the 64 patients. The complication rate included 14 surgical revisions.
The clinical impact of CSF shunts is relevant in neurosurgical units; as relevant is the complication rate for over- or under-drainage. Therefore, technical innovations in this field—such as adjustable gravitational valves—are welcome. However, the major limitations of this retrospective study are the short follow-up and the effortless statistical analysis. This is particularly relevant for lifelong permanent implants.
Nevertheless, the article gives us a motivating perspective for the successful managment of tricky shunt-related problems. The authors should be complimented for the simple presentation of multifaceted heterogeneous data. The proSA valve appears to overcome the overdrainage problems in hydrocephalus patients.
Larger prospectictively comparative studies, a longer follow-up and a comprehensive statistical analysis are required to validate the presented data.
Alex Alfieri
Neuruppin, Germany
Rights and permissions
About this article
Cite this article
Tschan, C.A., Antes, S., Huthmann, A. et al. Overcoming CSF overdrainage with the adjustable gravitational valve proSA. Acta Neurochir 156, 767–776 (2014). https://doi.org/10.1007/s00701-013-1934-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00701-013-1934-3